Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer
Rebecca M. Borneman(USA Mitchell Cancer Institute), Luciana Madeira da Silva(USA Mitchell Cancer Institute), Adam B. Keeton(Washburn University), Antonio Ward(USA Mitchell Cancer Institute), Alla Musiyenko(USA Mitchell Cancer Institute), Kevin J. Lee(University of Alabama at Birmingham), Steven McClellan(University of South Alabama), David K. Crossman(University of Alabama at Birmingham), Ileana Aragon(University of South Alabama), Joel Andrews(USA Mitchell Cancer Institute), Elaine Gavin(USA Mitchell Cancer Institute), Gary A. Piazza(Auburn University), Wito Richter(University of South Alabama), Kristy Berry(USA Mitchell Cancer Institute), Jennifer Scalici(University of Virginia Health System), Xi Chen(Baylor College of Medicine), Annelise Wilhite(USA Mitchell Cancer Institute)
Cited by 20
Related Papers
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
|Nature Genetics|2015|400
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
|Cancer Cell|2013|320
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303